Where does Gilead Connecticut, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gilead Connecticut, Inc. ranks #16,053 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gilead Connecticut, Inc. hold?

Gilead Connecticut, Inc. holds 18 US utility patents granted between 2015 and 2019, spanning 10 technology areas.

What is Gilead Connecticut, Inc.'s Innovation Score?

Gilead Connecticut, Inc. has an Innovation Score of 31.6 out of 100 (38th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Gilead Connecticut, Inc. focus on?

Gilead Connecticut, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 18 patents, ranking #1,084 of 6,058 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Gilead Connecticut, Inc.'s patent grant rate increasing or decreasing?

Gilead Connecticut, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Gilead Connecticut, Inc.'s patents?

Gilead Connecticut, Inc.'s patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gilead Connecticut, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Gilead Connecticut, Inc.

USPTO PatentsView assignee record - 18 granted patents across 10 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gilead ranks #16,053 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 10 technology areas.

#16,053
of 49,997 US assignees by volume: 38th percentile
by Innovation Score (31.6/100): 17.0
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16053 · US Corporation #16,053 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,053/49,997
PHOTO-FINISH Gebr Bode & KG
CPC-FOCUS A61P · 10 areas
INNOV-THIN 31.6/100
CLAIMS-RICH 17.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gebr. Bode GMBH & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gilead’s 31.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (32%) Velocity 0.0 pts (0%) Breadth 11.2 pts (35%) Claim depth 10.2 pts (32%)

Qualcomm Incorporated · highest

85
Astora Women's Health · near

32
Carpenter Technology · near

32
Gilead Connecticut · this assignee

32
Marty Gilman · near

32
WaterGuru · near

32
3D Lighting… · lowest

7

What this shows Gilead's Innovation Score is 31.6/100 (38th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Gilead?

Each dot is one of Gilead’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gilead’s own 17.0 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Gilead vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gilead's grants concentrate

Gilead Connecticut, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (5 grants) versus a trough of 2 in 2019. By volume, Gilead sits between Gebr. Bode GMBH & Co. KG and Grand Rounds, Inc..

Gebr Bode & KG

18
Gehl Foods

18
Gelest

18
Geoservices Equip…

18
Glaxosmithkline C…

18
Global Graphics S…

18
GONG io

18
Grand Rounds

18
Gilead Connecticut ◀

18

What this shows Gilead holds 18 patents at rank #16,045, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gilead

By rank, the assignees closest to #16,045 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Gilead's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Gilead, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Gilead ranks #1,084 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Marty Gilman, Inc. 32 Carpenter Technology Corporation 32 WaterGuru, Inc. 32 Astora Women's Health, LLC 32

Gilead's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 38th percentile higher than 38% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Gilead Connecticut, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	22.2%
2016	3	16.7%
2017	4	22.2%
2018	5	27.8%
2019	2	11.1%

Which technologies does Gilead Connecticut, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 18

C07D - Heterocyclic Compounds 18

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

C07C - Acyclic OR Carbocyclic Compounds 8

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 3

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 3

B29B - Preparation OR Pretreatment OF THE Material TO BE SHAPED; Making Granules OR PREFORMS; Recovery OF Plastics OR Other Constituents OF Waste Material Containing Plastics 3

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 3

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Gilead Connecticut, Inc.'s patent record in context - here's where to go next.

Gilead Connecticut, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #16,053 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gilead Connecticut, Inc. against Gebr. Bode GMBH & Co. KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.